Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2019-0319

2. Registrant Information.

Registrant Reference Number: ProPharma Group case #: 1-55287967

Registrant Name (Full Legal Name no abbreviations): Syngenta Canada Inc.

Address: 140 Research Lane, Research Park

City: Guelph

Prov / State: Ontario

Country: Canada

Postal Code: N1G4Z3

3. Select the appropriate subform(s) for the incident.

Human

4. Date registrant was first informed of the incident.

18-JAN-19

5. Location of incident.

Country: CANADA

Prov / State: QUEBEC

6. Date incident was first observed.

Unknown

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

Active(s)

PMRA Registration No. 27428      PMRA Submission No.       EPA Registration No. Unknown

Product Name: DEMAND CS INSECTICIDE

  • Active Ingredient(s)
    • LAMBDA-CYHALOTHRIN

7. b) Type of formulation.

Application Information

8. Product was applied?

Yes

9. Application Rate.

Unknown

10. Site pesticide was applied to (select all that apply).

Site: Res. - In Home / Rés. - à l'int. maison

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform II: Human Incident Report (A separate form for each person affected)

1. Source of Report.

Data Subject

2. Demographic information of data subject

Sex: Female

Age: >19 <=64 yrs / >19 <=64 ans

3. List all symptoms, using the selections below.

System

  • General
    • Symptom - Cancer
  • Eye
    • Symptom - Other
    • Specify - unspecified eye problems
  • Nervous and Muscular Systems
    • Symptom - Other
    • Specify - unspecified muscle problems
  • Respiratory System
    • Symptom - Other
    • Specify - unspecified breathing problems

4. How long did the symptoms last?

Unknown / Inconnu

5. Was medical treatment provided? Provide details in question 13.

Yes

6. a) Was the person hospitalized?

Unknown

6. b) For how long?

7. Exposure scenario

Non-occupational

8. How did exposure occur? (Select all that apply)

Contact with treated area

What was the activity? re-entering the home

9. If the exposure occured during application or re-entry, what protective clothing was worn? (select all that apply)

Unknown

10. Route(s) of exposure.

Unknown

11. What was the length of exposure?

Unknown / Inconnu

12. Time between exposure and onset of symptoms.

Unknown / Inconnu

13. Provide any additional details about the incident (eg. description of the frequency and severity of the symptoms, type of medical treatment, results from medical tests, outcome of the incident, amount of pesticide exposed to, etc.)

1-55287967 - The reporter indicates an exposure to a pesticide containing the active ingredient lambda-cyhalothrin. Starting approximately three years before the day of initial contact with the registrant, the reporter indicated the interior of her home was sprayed with the product every three weeks. The reporter indicated she developed cancer, muscle problems, breathing problems and eye problems an unknown amount of time after the exposure. The reporter indicated she had sought medical care, but no definitive cause was found. The reporter was advised to continue to work with her doctor as these symptoms would not be expected from normal product use. No additional information is available.

To be determined by Registrant

14. Severity classification.

Major

15. Provide supplemental information here.

Subform II: Human Incident Report (A separate form for each person affected)

1. Source of Report.

Other

2. Demographic information of data subject

Sex: Unknown

Age: >12 <=19 yrs / >12 <=19 ans

3. List all symptoms, using the selections below.

System

  • Nervous and Muscular Systems
    • Symptom - Other
    • Specify - unspecified muscle problems
  • Eye
    • Symptom - Other
    • Specify - unspecified eye problems
  • Respiratory System
    • Symptom - Other
    • Specify - unspecified breathing problems

4. How long did the symptoms last?

Unknown / Inconnu

5. Was medical treatment provided? Provide details in question 13.

Yes

6. a) Was the person hospitalized?

Unknown

6. b) For how long?

7. Exposure scenario

Non-occupational

8. How did exposure occur? (Select all that apply)

Contact with treated area

What was the activity? re entering the home

9. If the exposure occured during application or re-entry, what protective clothing was worn? (select all that apply)

Unknown

10. Route(s) of exposure.

Unknown

11. What was the length of exposure?

Unknown / Inconnu

12. Time between exposure and onset of symptoms.

Unknown / Inconnu

13. Provide any additional details about the incident (eg. description of the frequency and severity of the symptoms, type of medical treatment, results from medical tests, outcome of the incident, amount of pesticide exposed to, etc.)

1-55287967 - The reporter indicates her child was exposed to a pesticide containing the active ingredient lambda-cyhalothrin. Starting approximately three years before the day of initial contact with the registrant, the reporter indicated the interior of her home was sprayed with the product every three weeks. The reporter indicated her x-year-old child developed muscle problems, breathing problems and eye problems an unknown amount of time after the exposure. The reporter indicated she had sought medical care for her child, but no definitive cause was found. The reporter was advised to continue to work with the doctor as these symptoms would not be expected from normal product use. No additional information is available.

To be determined by Registrant

14. Severity classification.

Minor

15. Provide supplemental information here.

Subform II: Human Incident Report (A separate form for each person affected)

1. Source of Report.

Other

2. Demographic information of data subject

Sex: Unknown

Age: >19 <=64 yrs / >19 <=64 ans

3. List all symptoms, using the selections below.

System

  • Eye
    • Symptom - Other
    • Specify - unspecified eye problems
  • Nervous and Muscular Systems
    • Symptom - Other
    • Specify - unspecified muscle problems
  • Respiratory System
    • Symptom - Other
    • Specify - unspecified breathing problems

4. How long did the symptoms last?

Unknown / Inconnu

5. Was medical treatment provided? Provide details in question 13.

Yes

6. a) Was the person hospitalized?

Unknown

6. b) For how long?

7. Exposure scenario

Non-occupational

8. How did exposure occur? (Select all that apply)

Contact with treated area

What was the activity? re entry into the home

9. If the exposure occured during application or re-entry, what protective clothing was worn? (select all that apply)

Unknown

10. Route(s) of exposure.

Unknown

11. What was the length of exposure?

Unknown / Inconnu

12. Time between exposure and onset of symptoms.

Unknown / Inconnu

13. Provide any additional details about the incident (eg. description of the frequency and severity of the symptoms, type of medical treatment, results from medical tests, outcome of the incident, amount of pesticide exposed to, etc.)

1-55287967 - The reporter indicates her child was exposed to a pesticide containing the active ingredient lambda-cyhalothrin. Starting approximately three years before the day of initial contact with the registrant, the reporter indicated the interior of her home was sprayed with the product every three weeks. The reporter indicated her x-year-old child developed muscle problems, breathing problems and eye problems an unknown amount of time after the exposure. The reporter indicated she had sought medical care for her child, but no definitive cause was found. The reporter was advised to continue to work with the doctor as these symptoms would not be expected from normal product use. No additional information is available.

To be determined by Registrant

14. Severity classification.

Minor

15. Provide supplemental information here.